CTVEF (Certive Solutions) Research & Development: $0.00 Mil (TTM As of Feb. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Certive Solutions Research & Development?

Certive Solutions CTVEF -99.94% Research & Development is $0.00 Mil as of Feb. 2024.

Research & Development is the aggregate amount of research and development expenses during the year. Certive Solutions's Research & Development for the three months ended in Feb. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 was $0.00 Mil.

Certive Solutions  (OTCPK:CTVEF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Certive Solutions Research & Development Related Terms

Certive Solutions Research & Development Historical Data

* Premium members only.

The historical data trend for Certive Solutions's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Certive Solutions Research & Development Chart

Certive Solutions Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Certive Solutions Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Certive Solutions Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Certive Solutions (CTVEF) has a Research & Development of $0.00 Mil as of Feb. 2024. Research and development expense is the total cost for research and development activities. View historical data on Certive Solutions and its competitors.
Is Certive Solutions' Research & Development too high?
Certive Solutions' current Research & Development is $0.00 Mil.
How does Certive Solutions' Research & Development compare to ESSI and UPHL?
Certive Solutions' Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Certive Solutions and its competitors. Certive Solutions's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Certive Solutions stock overvalued right now?
Certive Solutions (CTVEF) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Certive Solutions (CTVEF), the current Research & Development is $0.00 Mil as of Feb. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Certive Solutions Business Description

Address 8149 North 87th Place, Scottsdale, AZ, USA, 85258
Certive Solutions Inc is a service provider in the Revenue Cycle Management (RCM) segment of the United States healthcare industry. The company provides claims audit and recovery solutions. Along with its subsidiaries, the Titan and Omega divisions provide retrospective claim audits against payer contracts, identify underpayments, and rebill and collect revenues for hospital customers. Its lines of business include billing support, claim audit and recovery, consulting services and chargemaster/lost charge recovery. The Company currently provides services to hospital clients enhancing the efficiency and effectiveness of lost charge recovery services, in revenue-sharing relationships that improve hospital clients net operating results.